EE+ POEM Archive
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease is a topic covered in the EE+ POEM Archive.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Slawson, David C., et al., editors. "No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease. Accessed May 28, 2020.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. John Wiley & Sons. Retrieved May 28, 2020, from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease
No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2020 May 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
ID - 1314901
ED - Slawson,David C,
ED - Shaughnessy,Allen F,
ED - Ebell,Mark H,
ED - Barry,Henry,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
